CN
CN

Webinar

Insights from target to IND

Learn More

Chem-on-Demand

Bridging Synthesis to Your Success

Learn More

Latest Sciences

Recent posters and published articles

Learn More

Enabling Unbounded Possibilities

Delivering Comprehensive End-to-End Discovery Solutions

Learn More
WuXi AppTec Research Service Platform

Delivering our partners preclinical discoveries through world class capabilities,

directed by teams with a reputation for collaboration and scientific excellence

Learn More
Latest Science
Webinar
Cutting-edge synthetic technology and expertise in special chemical matters have been centralized to form a variety of special chemistry platforms.

Webinar

Insights from target to IND

Cutting-edge synthetic technology and expertise in special chemical matters have been centralized to form a variety of special chemistry platforms.

Magical Power of QM
With powerful workstations, state of the art software, and our expertise on reaction QM analyses, real-time incorporations of such calculations in prospective analyses become routines in Research Service Division.

Magical Power of QM

To Empower Organic Syntheses

With powerful workstations, state of the art software, and our expertise on reaction QM analyses, real-time incorporations of such calculations in prospective analyses become routines in Research Service Division.

Bifunctional Molecules
Bifuctional molecules are opening up once-inaccessible targets and enabling development of drugs that are less susceptible to target protein mutations.

Bifunctional Molecules

A Diverse New Modality That Unlocks New Target Classes

Bifuctional molecules are opening up once-inaccessible targets and enabling development of drugs that are less susceptible to target protein mutations.

CRISPR Library Screen
Cancer is a genetic disease. Over time, somatic mutations accumulate and drive the proliferation of tumor cells. Knowledge of that process has spurred systematic efforts to identify genes essential to the survival of different cancer cells.

CRISPR Library Screen

A Powerful Tool For Identifying Novel Tumor Targets

Cancer is a genetic disease. Over time, somatic mutations accumulate and drive the proliferation of tumor cells. Knowledge of that process has spurred systematic efforts to identify genes essential to the survival of different cancer cells.

Science
Identification and characterization of new bifunctional molecules including degraders using synergistic power of fragment and DEL screening, biophysics and structural biology

Science

Enabling Technology for Targeted Protein Degradation

Identification and characterization of new bifunctional molecules including degraders using synergistic power of fragment and DEL screening, biophysics and structural biology

HitS
WuXi AppTec HitS Unit provides a one-stop Target-to-Hit services that enable companies in the pharmaceuticals, biotech and academics worldwide to seek premium drug discovery. As an innovation-driven and customer-focused unit, HitS helps our partners to improve the productivity of advancing hit discovery through high-quality and cost-effective solutions. With industry-leading capabilities such as protein science, biophysics, DNA-encoded library technology, and structure-based drug design, HitS is committed to drive toward the realization of the vision that every drug can be made and every disease can be treated.

HitS

Partner of ‘Target-to-Hit’ discovery

WuXi AppTec HitS Unit provides a one-stop Target-to-Hit services that enable companies in the pharmaceuticals, biotech and academics worldwide to seek premium drug discovery. As an innovation-driven and customer-focused unit, HitS helps our partners to improve the productivity of advancing hit discovery through high-quality and cost-effective solutions. With industry-leading capabilities such as protein science, biophysics, DNA-encoded library technology, and structure-based drug design, HitS is committed to drive toward the realization of the vision that every drug can be made and every disease can be treated.

Upcoming Events

EFMC-ISMC 2021 XXVI EFMC International Symposium on Medicinal Chemistry

August 29 - September 2, 2021

Swiss Biotech Day 2021

September 7, 2021

NAFLD Summit 2021

September 16-18, 2021

Discovery on Target

September 27-30, 2021

Discovery UK

October 26-27, 2021

SITC 2021

November 10-14, 2021

The Liver Meeting 2021

November 12-16, 2021

Immuno UK

November, 2021